Clinical trial
Severe Anemia Treatment Trials, Pakistan
NCT00116493 · Johns Hopkins Bloomberg School of Public Health, Other · Completed
Key facts
| NCT number | NCT00116493 |
|---|---|
| Title | Severe Anemia Treatment Trials, Pakistan |
| Official title | Evaluation of Anthelminthics and Multivitamins for Treatment of Severe Anemia in Pregnant Women and Children 6-24 Months of Age in Pakistan |
| Lead sponsor | Johns Hopkins Bloomberg School of Public Health, Other |
| Collaborators | Aga Khan University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Dietary Supplement, Drug |
| Interventions | Iron-folic acid and mebendazole, Mebendazole, Multivitamins, Mebendazole + Multivitamin |
| Enrollment | 1,009 |
| Start date | Apr 1, 2004 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jun 30, 2005 |
| Last update posted | Apr 9, 2012 |
| Countries | Pakistan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: